Conclusion: patients with tumors in the mediastinum have significant impairments in voice and swallowing functions, especially when they are located in the anterior mediastinal region and Hodgkin lymphomas.RESUMO Objetivo: verificar as implica ções na voz e na deglutição em pacientes com diagnóstico de tumores localizados no mediastino. Métodos: o estudo foi realizado em 21 indivíduos com idades entre 18 e 60 anos, com diagnóstico de tumores localizado no mediastino. A coleta de dados foi realizada nos ambulatórios de Oncologia Clínica, OncoHematologia e Cirurgia Torácica Oncológica, e nas enfermarias das clínicas acima mencionadas de um hospital de referência em Oncologia. Os dados foram obtidos por meio da aplicação de um questionário próprio para a pesquisa, e da avali...
from #Medicine-SfakianakisAlexandros via o.lakala70 on Inoreader https://ift.tt/2Euh79M
via IFTTT
Πέμπτη 13 Δεκεμβρίου 2018
Voice and swallowing implications in patients with tumors in their mediastinum
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibrobl...
-
Background. Antitumor necrosis factor (anti-TNF) therapy is a highly effective but costly treatment for inflammatory bowel disease (IBD). Me...
-
Abstract Desmoplastic small round cell tumor (DSCRT) is a rare malignancy most often seen in the abdomen or pelvis of young men. Unfortuna...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nGQ2DC via IFTTT
-
Article content meets expectations Minimal relevance to assigned subject matter. Article content fails to meet all requirements Not Rubric f...
-
Objective To determine the association between neuroendocrine tumor (NET) biomarker levels and the extent of disease as assessed by 68 Ga DO...
-
Elementary school kids, on the other hand, can read, write, reason and think highly complex thoughts. Adele Faber and Elaine Mazlish, author...
-
by Mindaugas Paužuolis, Torsten Eich, Joachim Burman Background Natalizumab (NTZ) is a drug that has been widely used in the treatment of m...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου